Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. Juli 2025 06:04 ET | Quelle: Research and Markets

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The...
14. Juli 2025 05:56 ET | Quelle: Research and Markets

GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The GLP-1 Agonists Drug Pipeline...
10. Juli 2025 10:52 ET | Quelle: Research and Markets

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 2025-2034 | Expanding Clinical Trials and Increasing Insurance Coverage to Boost Growth Prospects

Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's...
25. Juni 2025 10:41 ET | Quelle: Research and Markets

Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 2025-2034: Emerging Markets and Biosimilars Present New Growth Avenues for GLP-1 Industry Expansion

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The...
01. Oktober 2024 04:35 ET | Quelle: Research and Markets

$49.3 Bn GLP-1 Markets 2024-2035 with Boehringer Ingelheim, Eli Lilly, Novo Nordisk Dominating

Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type...